Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Y010045 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | Z006738 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 3 | Z006738 | — |
No additional AE; Nurse reported that a patient inadvertently received the third dose of VARIVAX due to lack of vaccination record at the time of the visit. The patient received first dose of VARIVAX (y010045 5/29/2026) on 10/10/2024, second dose (z006738 3/31/20; This spontaneous report was received from Nurse and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 10-Oct-2024, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) powder and solvent for solution for injection, 1st dose (1.00 dosage form) (total) (Batch/Lot Number: Y010045) (Expiration date: 29-May-2026) (Dose Text: 1 dose). On 05-Feb-2026, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) powder and solvent for solution for injection, 2nd dose (1.00 dosage form) (total) (Batch/Lot Number: Z006738) (Expiration date: 31-Mar-2027) (Dose Text: 1 dose). On 05-Mar-2026, the patient inadvertently received the third dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) powder and solvent for solution for injection due to lack of vaccination record at the time of the visit (1.00 dosage form) (total) (Batch/Lot Number: Z006738) (Expiration date: 31-Mar-2027) (Extra dose administered). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not reported). The suspect vaccine was administered as prophylaxis. The outcome of the events was not provided. The action taken with the suspect products was not applicable.
DILUENT MRK